Pharmaceuticals
Advent, Baxter in race to acquire Gland Pharma
15 Apr 2016
Valeant Pharmaceuticals hires investment banks to review strategic options
15 Apr 2016
Valeant Pharmaceuticals International Inc, one of the most aggressive acquirers in the global pharmaceuticals industry, is considering selling "non-core assets" to help trim its $30-billion debt pile
Theranos may lose licence; top execs face ban
14 Apr 2016
Pfizer calls halt to $160bn merger with Allergan: report
06 Apr 2016
The decision comes after the US Treasury unveiled new rules that proposed to limit companies’ ability to participate in inversion transactions if they have been engaged in acquisitions within the past 36 months
